New Respiratory Support Devices Improve Patient Ventilation

The Respironics V60 ventilator offers traditional invasive respiratory support by intubation, or noninvasive ventilation (NIV) support via a patient facemask. The V60 uses Auto-Trak technology to help ensure patient synchrony and therapy acceptance, specific challenges facing NIV. By providing autoadaptive leak compensation, inspiratory triggering, and expiratory cycling, the Auto-Trak feature delivers optimal synchrony in the face of dynamic leak and changing patient demand.

The Respironics V200 Critical Care ventilator integrates autoadaptive technology and provides ventilation for neonatal, pediatric, and adult patients. An innovative "speaking mode" provides the tracheostomized patient the ability to speak without the need for costly external valves. The speaking mode helps boosts patient confidence, making them more apt to progress through the day and work with physical therapy, nursing, and respiratory therapy.

The Trilogy100 ventilator is a highly-versatile, lightweight life-support ventilator with internal and detachable batteries for added portability, with advanced features such as autoadaptive technology, volume- or pressure- control BiPAP technology for greater versatility, and the ability to ventilate with either a mask or a tracheal tube. All three devices are designed to address the ventilation care challenges that clinicians face on a daily basis, such as treating respiratory failure from exacerbations of chronic obstructive pulmonary disease (COPD), while avoiding ventilator-associated pneumonia. The Respironics V60, V200, and Trilogy100 ventilators are products of Royal Philips Electronics (Eindhoven, The Netherlands).

"Trilogy100 has been designed to help caregivers and clinicians more easily administer care in the home and allow patients to be as active as possible while using the ventilator," said John Frank, vice president and general manager of home respiratory care for Philips Healthcare. "Its ease of use, versatility, and portability make Trilogy100 a significant advancement in home respiratory support."

"Noninvasive ventilation has been proven to significantly reduce the incidence of ventilator-associated pneumonia (VAP), and it has also been shown to shorten the time patients spend in the hospital," added Randy Whitfield, general manager of hospital respiratory care for Philips Healthcare.

Related Links:
Royal Philips Electronics